The Adrenal Gland: Central Relay in Health and Disease

Martin Reincke; Felix Beuschlein; Stefan Bornstein; Graeme Eisenhofer; Martin Fassnacht; Nicole Reisch; Tracy Ann Williams

doi:10.1055/a-0752-4176

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2019; 127(02/03): 81-83
DOI: 10.1055/a-0752-4176

Editorial

The Adrenal Gland: Central Relay in Health and Disease

Martin Reincke

¹Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, Germany

,

Felix Beuschlein

¹Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, Germany

²Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitäts-Spital Zürich, Zürich, Switzerland

,

Stefan Bornstein

³Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany

,

Graeme Eisenhofer

³Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany

⁴Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Dresden, Germany

,

Martin Fassnacht

⁵Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany

,

Nicole Reisch

¹Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, Germany

,

Tracy Ann Williams

¹Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, Germany

⁶Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy

› Author Affiliations

Abstract

Diseases of the adrenal gland are as important for the general practitioner as for the endocrine specialist. The high prevalence of some adrenal endocrinopathies, such as adrenal incidentalomas (1–2% of the population) and primary aldosteronism (6% of hypertensives), which affect millions of patients, makes adrenal diseases a relevant health issue. The high morbidity and mortality of some of the rarer adrenal diseases, i. e., Addison’s disease and Cushing’s syndrome ([Table 1]), make early detection and appropriate treatment such a challenge for the health care system.

Key words

Addison disease - congenital adrenal hyperplasia - Cushing’s syndrome - hypercortisolism - primary aldosteronism - adrenocortical carcinoma - pheochromocytoma - paraganglioma

Full Text

References

References
1 Prada ETA, Burrello J, Reincke M. et al. Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism. Hypertension. 2017; 70: 875-881. doi:10.1161/HYPERTENSIONAHA.117.10111.
2 Albani A, Theodoropoulou M, Reincke M. Genetics of Cushing's disease. Clin Endocrinol (Oxf) 2018; 88: 3-12. doi:10.1111/cen.13457.
3 Fassnacht M, Arlt W, Bancos I. et al. Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 2016; 175: G1-G34. doi:10.1530/EJE-16-0467.
4 Crona J, Taïeb D, Pacak K. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a molecular classification. Endocr Rev 2017; 38: 489-515 doi:10.1210/er.2017-00062.
5 Schilbach K, Junnila R, Bidlingmaier M.. The aldosterone to renin ratio as screening tool in primary aldosteronism. Exp Clin Endocrinol Diabetes 2019; 127: 84-92
7 Pérez-Rivas LG, Williams T, Reincke M.. Inherited forms of primary hyperaldosteronism: new genes, new phenotypes and proposition of a new classification. Exp Clin Endocrinol Diabetes 2018; 12: 93-99
6 Mulatero P, Tizzani D, Viola A. et al. Prevalence and characteristics of familial hyperaldosteronism: The PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension 2011; 58: 797-803 doi:10.1161/HYPERTENSIONAHA.111.175083.
8 Yang Y, Reincke M, Williams T.. Treatment of unilateral PA by adrenalectomy: Potential reasons for incomplete biochemical cure. Exp Clin Endocrinol Diabetes 2019; 127: 100-108
9 Williams TA, Lenders JWM, Mulatero P. et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: An international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017; 5: 689-699 doi:10.1016/S2213-8587(17)30135-3.
10 Fassnacht M, Terzolo M, Allolio B. et al. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med 2012; 366: 2189-2197. doi:10.1056/NEJMoa1200966.
11 Kroiss M, Deutschbein T, Schlötelburg W. et al. Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry.. Exp Clin Endocrinol Diabetes 2018;
12 Megerle F, Kroiss M, Hahner S, Fassnacht M. Advanced Adrenocortical Carcinoma - What to do when First-Line Therapy Fails?. Exp Clin Endocrinol Diabetes 2019; 127: 109-116
13 Nölting S, Grossman AB, Pacak K.. Metastatic Phaeochromocytoma: Spinning towards more promising treatment options. Exp Clin Endocrinol Diabetes 2019; 127: 117-128
14 Erlic Z, Beuschlein F. Metabolic alterations in patients with pheochromocytoma. Exp Clin Endocrinol Diabetes 2019; 127: 129-136
15 Schreiner F, Anand G, Beuschlein F.. Perioperative management of endocrine active adrenal tumors. Exp Clin Endocrinol Diabetes 2019; 127: 137-146
16 Petersenn S, Beckers A, Ferone D. et al. Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: Systematic review assessing criteria used to define remission and recurrence. Eur J Endocrinol. 2015; 172: R227-R239. doi:10.1530/EJE-14-0883.
17 Stalla GK, Ciato D, Dimopoulou C. Cushing's disease. Exp Clin Endocrinol Diabetes 2019; 127: 147-155
18 Kamilaris CDC, Faucz FR, Voutetakis A. Stratakis CA. et al. Carney complex. Exp Clin Endocrinol Diabetes 2019; 127: 156-164
19 Barthel A, Benker G, Berens K. et al. An update on Addison's disease. Exp Clin Endocrinol Diabetes 2019; 127: 165-170
20 Reisch N. Review of health problems in adult patients with congenital adrenal hyperplasia. Exp Clin Endocrinol Diabetes 2019; 127: 171-177
21 Di Dalmazi G.. Adrenal incidentaloma: picking out the high-risk patients. Exp Clin Endocrinol Diabetes 2019; 127: 178-184
22 http://www.dfg.de/gefoerderte_projekte/programme_und_projekte/listen/projektdetails/index.jsp?id=314061271